PhD, Masters, Honours
Chronic scarring (fibrosis) diseases account for ~45% of all deaths in the developed world. End stage chronic disease culminates in tissue scarring including of the liver, kidneys, heart and lungs and is the principal cause of morbidity and mortality from diseases of these organs (1). Fibrosis is characterized by considerable inter-individual variability with an estimated 50% heritability. The Storr Centre has made major contributions to the identification of the genetic architecture of tissue fibrosis. In this project, we seek to identify novel risk loci/variants for fibrosis. The project will involve working with human samples.
Supervisor: Dr. Mohammed Eslam email@example.com